The AI debate served as a microcosm of a broader theme at the summit: the realization that tackling today\u2019s healthcare challenges requires a team effort. Whether it\u2019s integrating new technologies or addressing equity issues, the message was clear\u2014global problems require collaborative solutions.<\/p>\n
Equity, in particular, stood out as a key theme throughout the event. It\u2019s not just about making sure everyone gets the same treatment, but about ensuring that resources are distributed in ways that account for real-world complexities. My own presentation focused on NICE\u2019s work to create strategic principles for evidence-limited domains, like public health, social care, and rare diseases\u2014areas that often get overlooked in traditional healthcare prioritization. This work, too, was rooted in collaboration. Developing these principles involved extensive engagement with stakeholders\u2014patients, policymakers, and professionals\u2014all of whom brought different perspectives to the table. Navigating these diverse viewpoints was challenging, but it ultimately led to richer, more innovative solutions that are both equitable and transparent.<\/p>\n
What we learned at NICE is that collaboration not only improves decision-making but also strengthens equity by ensuring that no voice is left unheard. Whether in public health, where the evidence is often less robust than in clinical trials, or in rare diseases, where patient numbers are small but needs are profound, collaboration ensures that we are making decisions that are inclusive and fair.<\/p>\n
Alric Ruether\u2019s talk on global disparities in access to medicines further highlighted this point. He posed a crucial question: Are we asking for the evidence we need? And more importantly, are we making sure that disadvantaged populations are represented in the data? Ruether\u2019s challenge to the audience was clear\u2014if we want to overcome global disparities in healthcare, we need to collaborate across borders, sharing data and resources to ensure that everyone, regardless of background or geography, benefits from advances in healthcare.<\/p>\n
As the summit drew to a close, I couldn\u2019t help but reflect on the overwhelming consensus: collaboration is the key to solving the biggest challenges we face in healthcare. Whether it\u2019s harnessing the power of AI, advocating for equity, or ensuring global data sharing, the only way forward is together. The Global Evidence Summit reinforced for me that while the path ahead may be complex, it is navigable\u2014so long as we continue to work together, share our knowledge, and remain committed to equitable healthcare for all.<\/p>\n
Author<\/strong><\/p>\n Sin\u00e9ad Peare<\/strong><\/p>\n Sin\u00e9ad is the lead Hepatology Pharmacist at Guy\u2019s & St Thomas\u2019 NHS Trust, with a passion for advancing health equity, global healthcare access, and medicines policy. With a rich background in international health and equity policy, she recently served as the Chief Pharmaceutical Officer\u2019s Clinical Fellow at NICE, where she led the development of strategic principles for rare diseases to improve equity of prioritisation for rare disease topics.<\/p>\n Sin\u00e9ad\u2019s career has taken her across the globe, in Myanmar she established the country\u2019s first Medicines Information service and led a reform of the pharmacy curriculum, and then in Hong Kong she implemented the largest COVID vaccination centre and published literature to improve equity in childhood vaccination.<\/p>\n Driven by her passion for health equity and her hunger for equal access to medicines globally Sin\u00e9ad aspires to continue her work internationally, advancing access to essential medicines and supporting the elimination of Hepatitis and HIV worldwide.<\/p>\n Declaration of interests<\/b><\/p>\n I have read and understood the BMJ Group policy on declaration of interests and declare the following interests: none.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":" Collaboration \u2013 it was the word on everyone\u2019s lips at the Global Evidence Summit in Prague. With over 1,800 delegates and more than 2,000 abstracts submitted, the event was a vivid demonstration of what happens when knowledge, expertise, and diverse perspectives come together. Organized by Cochrane, the Guidelines International Network (GIN), and the Joanna Briggs […]<\/p>\n![\"\"](\"http:\/\/blogs.bmj.com\/bmjleader\/files\/2024\/11\/Sinead2-150x150.jpg\")
<\/p>\n